Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada
- PMID: 15528744
- PMCID: PMC525145
- DOI: 10.1128/JCM.42.11.5364-5367.2004
Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada
Abstract
The fim genes which code for the fimbria protective antigens present in both the inactivated whole-cell and acellular vaccines were analyzed in 86 Canadian Bordetella pertussis isolates. At least one of the novel mutations identified was found to involve a surface epitope that has been mapped by serum antibodies from infected or vaccinated subjects.
Figures


Similar articles
-
Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.Vaccine. 2018 Mar 7;36(11):1345-1352. doi: 10.1016/j.vaccine.2018.02.017. Epub 2018 Feb 9. Vaccine. 2018. PMID: 29433898
-
Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine.Can J Microbiol. 2005 Oct;51(10):887-92. doi: 10.1139/w05-079. Can J Microbiol. 2005. PMID: 16333349
-
Small mutations in Bordetella pertussis are associated with selective sweeps.PLoS One. 2012;7(9):e46407. doi: 10.1371/journal.pone.0046407. Epub 2012 Sep 28. PLoS One. 2012. PMID: 23029513 Free PMC article.
-
Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.Expert Rev Vaccines. 2014 Sep;13(9):1135-46. doi: 10.1586/14760584.2014.932254. Epub 2014 Jun 23. Expert Rev Vaccines. 2014. PMID: 24953157 Review.
-
The advent of recombinant pertussis vaccines.Biotechnology (N Y). 1990 Nov;8(11):1002-5. doi: 10.1038/nbt1190-1002. Biotechnology (N Y). 1990. PMID: 1366927 Review. No abstract available.
Cited by
-
Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis.PLoS One. 2011 Mar 10;6(3):e17797. doi: 10.1371/journal.pone.0017797. PLoS One. 2011. PMID: 21423776 Free PMC article.
-
Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009.J Clin Microbiol. 2013 Feb;51(2):422-8. doi: 10.1128/JCM.02036-12. Epub 2012 Nov 21. J Clin Microbiol. 2013. PMID: 23175253 Free PMC article.
-
Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease.Clin Vaccine Immunol. 2012 Nov;19(11):1776-83. doi: 10.1128/CVI.00355-12. Epub 2012 Sep 5. Clin Vaccine Immunol. 2012. PMID: 22956654 Free PMC article.
-
Comparative genomics of prevaccination and modern Bordetella pertussis strains.BMC Genomics. 2010 Nov 11;11:627. doi: 10.1186/1471-2164-11-627. BMC Genomics. 2010. PMID: 21070624 Free PMC article.
-
Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains.PLoS One. 2007 Sep 19;2(9):e904. doi: 10.1371/journal.pone.0000904. PLoS One. 2007. PMID: 17878939 Free PMC article.
References
-
- Abdillahi, H., and J. T. Poolman. 1987. Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol. Lett. 48:367-371. - PubMed
-
- Bentsi-Enchill, A., S. A. Halperin, J. Scott, K. MacIsaac, and P. Duclos. 1997. Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population. Vaccine 15:301-306. - PubMed
-
- Boursaux-Eude, C., S. Thiberge, G. Carletti, and N. Guiso. 1999. Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine. Vaccine 17:2651-2660. - PubMed
-
- Cassiday, P., G. Sanden, K. Heuvelman, F. Mooi, K. M. Bisgard, and T. Popovic. 2000. Polymorphisms in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J. Infect. Dis. 182:1402-1408. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Molecular Biology Databases